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Will it be possible to regulate human aging with drugs? 
Will it be possible to regulate human aging with some kind of drug? Could healthy elders work for a longer period of time reducing the burden of
healthcare? Nowadays, due to the improvement in life quality and the progress achieved in medicine, nearly everybody above 65 on the USA suffers 1
to 3 aging-associated diseases, therefore, elucidating the causes of these diseases and aging itself is becoming increasingly important.
Introduction
The aim of this review is to understand the mechanisms involved in
human aging and to discuss the functionality of the most tested drugs
to date that potentially regulate them.
Aims
Search for papers in PubMed and PMC. Keywords used for the research:
aging, mTOR, rapamycin, caloric restriction, sirtuins, resveratrol.
Elaboration of a figure summarizing the pathways and drugs discussed.
Methodology
Genetics of aging and tested drugs
Even if a drug that slowed aging without secondary effects was found it does not seem likely that we see it approved. Due to the long duration and
high costs associated to prevention trials, pharmaceutical companies focus on treatment ones. In addition to that, aging is not considered a disease, so
new parameters like fragility and new aging altered biomarkers like microRNA serum levels should be accepted te begin treating aging as a disease.
Conclusions
Rapamycin
Capable of extending lifespan in mice by 
15% in females and 10% in males. 
Capable of delaying a subset of AAD.
SIRT1
Resveratrol STACs
SIRT1 deficiency results in elevated levels 
of mTOR signalling. Overexpression of 
SIRT1 in mice brain results in extended 
lifespan. 
Metformin
Widely used for treating type II diabetes 
and beneficial for cardiovascular disease 
and some types of cancer. It extends 
lifespan in mice by a 5%
Statins
Statins lead to reduced intracelular LDL-
associated cholesterol and prove
beneficial in cardiovascular disease. 
They reduce levels of reactive oxygen 
and stabilize telomeric structures .
